¿¨¿¨Íå88

¹ÉƱÐÅÏ¢£¨01093.HK)

EN ·±Ìå / ¼òÌå /

¹«Ë¾ÐÂÎÅ

COMPANY NEWS

°²¸´Àû¿Ë?ÖÎÁÆÃ«Ã¹¾ú²¡ÁÆÐ§ÓëÇå¾²ÐÔµÄÒ»ÏîÕæÊµÌìÏÂÑо¿Ð§¹û

¡¡ Ðû²¼Ê±¼ä£º2026-02-25| ×÷ÕߣºÊ¯Ò©¼¯ÍÅ
½üÆÚ £¬£¬£¬£¬£¬£¬ £¬¸´µ©´óѧÁ¥ÊôÎ÷ÔÀÒ½ÔºÖìÀûƽ½ÌÊÚÔÚ¹ú¼ÊÆÚ¿¯¡¶BMC Infectious Diseases¡·½ÒÏþÁËÌâΪ¡°Efficacy and safety of amphotericin B colloidal dispersion in the treatment of mucormycosis: a real-world observation¡±µÄÕæÊµÌìÏÂÑо¿ £¬£¬£¬£¬£¬£¬ £¬¸ÃÑо¿ÆÀ¹ÀÁËÁ½ÐÔÃ¹ËØBµ¨¹Ì´¼ÁòËáõ¥¸´ºÏÎABCD £¬£¬£¬£¬£¬£¬ £¬ÉÌÆ·Ãû£º°²¸´Àû¿Ë?£©ÖÎÁÆÃ«Ã¹¾ú²¡µÄÁÆÐ§ÓëÇå¾²ÐÔ £¬£¬£¬£¬£¬£¬ £¬ÎªÁÙ´²ÌṩÁËеÄÓÐÁ¦Ö¤¾Ý¡£ ¡£¡£¡£¡£

Ñо¿¸Å¿ö

ëù¾ú²¡ÊÇÒ»ÖÖÖÂËÀÂʼ«¸ßµÄÇÖÏ®ÐÔÕæ¾ú²¡ £¬£¬£¬£¬£¬£¬ £¬³£¼ûÓÚÌÇÄò²¡¡¢ÑªÒºÏµÍ³¶ñÐÔÖ×Áö¼°ÃâÒß¹¦Ð§µÍÏÂÈËȺ¡£ ¡£¡£¡£¡£ÓÉÓÚÓÐÓÿ¹Õæ¾úÒ©ÎïÑ¡ÔñÓÐÏÞ £¬£¬£¬£¬£¬£¬ £¬ÖÎÁÆÌôÕ½ÖØ´ó¡£ ¡£¡£¡£¡£Á½ÐÔÃ¹ËØBÊÇëù¾ú²¡µÄ»ù´¡ÖÎÁÆÒ©Îï £¬£¬£¬£¬£¬£¬ £¬µ«¹Å°å¼ÁÐ͵ÄÉö¶¾ÐÔµÈÎÊÌâÏÞÖÆÁËÆäÓ¦Óᣠ¡£¡£¡£¡£¹ú²úABCD×Ô2021Äê»ñÅúÉÏÊÐÒÔÀ´ £¬£¬£¬£¬£¬£¬ £¬Ìá¸ßÁËÒ©ÎïµÄ¿É¼°ÐÔ¡£ ¡£¡£¡£¡£

±¾Ñо¿ÎªÒ»Ïîµ¥ÖÐÐÄ¡¢»ØÊ×ÐÔ¡¢ÕæÊµÌìÏÂÑо¿ £¬£¬£¬£¬£¬£¬ £¬ÄÉÈë2021Äê8ÔÂÖÁ2024Äê4ÔÂÔÚÎ÷ÔÀÒ½Ôº½ÓÊÜABCDÖÎÁƵÄ38Àýëù¾ú²¡»¼Õß¡£ ¡£¡£¡£¡£Ñо¿Ö¼ÔÚÆÀ¹Àºã¾Ã¡¢µÍ¼ÁÁ¿ABCDÔÚ³õʼÖÎÁƺÍÕü¾ÈÖÎÁÆÖеÄÁÆÐ§ÓëÇå¾²ÐÔ £¬£¬£¬£¬£¬£¬ £¬²¢ÆÊÎöÓ°Ïì90ÌìÔ¤ºóµÄÒòËØ¡£ ¡£¡£¡£¡£

Ñо¿Ð§¹û

±¾Ñо¿¹²ÄÉÈë38Àýëù¾ú²¡»¼Õß £¬£¬£¬£¬£¬£¬ £¬ÆäÖзÎëù¾ú²¡×îΪ³£¼û£¨60.5%£© £¬£¬£¬£¬£¬£¬ £¬ÌÇÄò²¡ÊÇÖ÷ÒªµÄΣÏÕÒòËØ£¨55.3%£© £¬£¬£¬£¬£¬£¬ £¬¸ùù¾úÊôΪ×î³£¼ûµÄÖ²¡¾ú¡£ ¡£¡£¡£¡£

ÔÚÖÎÁÆ·½Ãæ £¬£¬£¬£¬£¬£¬ £¬ABCD³õʼÖÎÁƵÄÖÐλ¼ÁÁ¿Îª2.3 mg/kg/Ìì £¬£¬£¬£¬£¬£¬ £¬ÖÐλÓÃÒ©ÌìÊý38Ì죨IQR 14¨C71£© £¬£¬£¬£¬£¬£¬ £¬ÁÙ´²ÓÐÓÃÂÊ´ï63.0% £»£»£» £»£»£»£»£»Õü¾ÈÖÎÁƵÄÖÐλ¼ÁÁ¿Îª2.5 mg/kg/Ìì £¬£¬£¬£¬£¬£¬ £¬ÖÐλÓÃÒ©ÌìÊý31Ì죨IQR 22¨C68£© £¬£¬£¬£¬£¬£¬ £¬ÁÙ´²ÓÐÓÃÂÊ´ï82.4%¡£ ¡£¡£¡£¡£ÆäÖÐ26.3%µÄ»¼ÕßÍŽáʹÓÃABCDÓëßòÀàÒ©Îï £¬£¬£¬£¬£¬£¬ £¬Ö÷ÒªÓÃÓÚÎ£ÖØ²¡Àý £»£»£» £»£»£»£»£»34.2%µÄ»¼Õß½ÓÊÜÁËÊÖÊõÖÎÁÆ £¬£¬£¬£¬£¬£¬ £¬Æä90ÌìÉúÑÄÂÊΪ76.9%¡£ ¡£¡£¡£¡£

Çå¾²ÐÔ·½Ãæ £¬£¬£¬£¬£¬£¬ £¬ÒԵͼØÑªÖ¢£¨39.5%£©ºÍѪ¼¡ôûÉý¸ß£¨36.8%£©×îΪ³£¼û £¬£¬£¬£¬£¬£¬ £¬Í¨³£·ºÆðÔÚÓÃÒ©ºó3-4ÖÜ £¬£¬£¬£¬£¬£¬ £¬µ«´ó¶¼Îª1-2¼¶ £¬£¬£¬£¬£¬£¬ £¬½ö1ÀýÒòÑÏÖØ²»Á¼·´Ó¦ÖÐÖ¹ÖÎÁÆ¡£ ¡£¡£¡£¡£

Ô¤ºóÆÊÎöÏÔʾ £¬£¬£¬£¬£¬£¬ £¬»¼Õß30ÌìºÍ90ÌìÈ«ÒòéæÃüÂÊ»®·ÖΪ10.5%ºÍ15.8% £¬£¬£¬£¬£¬£¬ £¬1Äê×ÜÉúÑÄÂÊ´ï81.1%¡£ ¡£¡£¡£¡£¶àÒòËØÆÊÎöÌáÐÑ £¬£¬£¬£¬£¬£¬ £¬»ùÏßʹÓÃÌÇÆ¤Öʼ¤ËØÊÇÓ°Ïì90ÌìÉúÑÄÂʵÄ×ÔÁ¦Î£ÏÕÒòËØ£¨HR 9.44 £¬£¬£¬£¬£¬£¬ £¬P=0.007£©¡£ ¡£¡£¡£¡£

¿¨¿¨Íå88¡¤(Öйú´ó½)¿Í»§¶Ë

ͼ£º38ÀýABCDÖÎÁÆÃ«Ã¹¾ú²¡»¼Õߵĸſö


Ñо¿½áÂÛ£º

ºã¾ÃµÍ¼ÁÁ¿Ê¹ÓÃABCD¼Æ»®¶Ôëù¾ú²¡µÄ³õʼÖÎÁƺÍÕü¾ÈÖÎÁƾùÏÔʾ³öÓÅÒìµÄÇå¾²ÐÔºÍÓÐÓÃÐÔ¡£ ¡£¡£¡£¡£Ñо¿Í¬Ê±ÌáÐÑ £¬£¬£¬£¬£¬£¬ £¬»ùÏ߯ÚʹÓÃÌÇÆ¤Öʼ¤ËصϼÕßéæÃüΣº¦ÏÔÖøÉý¸ß £¬£¬£¬£¬£¬£¬ £¬ÁÙ´²Ó¦ÓèÒԸ߶ȹØ×¢¡£ ¡£¡£¡£¡£

²Î¿¼ÎÄÏ×£º

Jiang YK, Qiu WJ, Cao Y, et al. Efficacy and safety of amphotericin B colloidal dispersion in the treatment of mucormycosis: a real-world observation. BMC Infect Dis. Published online February 10, 2026.



¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿